National Cancer Institute awards $2.47 million for CBD neuropathy research

The National Cancer Institute awarded Temple University $2.47 million for a three-year preclinical project comparing nanoemulsion CBD formulations for chemotherapy-induced nerve pain and testing whether they interfere with cancer treatment. Oklahoma product developers should treat the grant as an R&D signal, not clinical proof or authorization for treatment claims.